Memphis, United States
SweetBio, Inc., founded in 2015 and headquartered in the United States, operates at the intersection of the Biotechnology, Health Care, Manufacturing, and Medical Devices industries. The company has positioned itself as a pioneering force in the wound care sector through its innovative, FDA-cleared collagen and honey-integrated products, emphasizing their mission of "#woundcareforall".
Noteworthy is SweetBio, Inc.'s achievement in securing participation from prominent investors, such as Apple during its last known investment round in August 2021. This backing underscores the potential scalability and market appeal of SweetBio’s novel solutions. For investors seeking opportunities in the burgeoning health tech space, SweetBio, Inc. offers both a robust commercial-ready product line and a strong operational foundation poised for future growth.
